Table 3.
Comparison of antifungal susceptibility between the UAE strains, Finland strains and the saliva strains with reference strains C. albicans (ATCC90028) and C. parapsilosis (ATCC 22019)
| Strain | N | Amphotericin B Mean (SD) |
p value | Fluoconazole Mean (SD) |
p value | Ketoconazole Mean (SD) |
p value | Nystatin Mean (SD) |
p value |
|---|---|---|---|---|---|---|---|---|---|
|
C. albicans ATCC 90028 |
1 | 1.04 (0.36) | 0.62 (0.00) | 2.50 (0.00) | 1.66 (0.72) | ||||
|
C. parapsilosis ATCC 22019 |
1 | 0.41 (0.18) | 1.67 (0.72) | 0.26 (0.09) | 0.62 (0.00) | ||||
|
UAEa C. albicans |
4 | 1.09 (0.46) |
0.051 NS |
0.62 (0.17) | 0.036b | 1.41 (1.04) |
0.947 NS |
1.25 (0.33) |
0.213 NS |
|
Finland C. albicans |
4 | 0.55 (0.10) | 0.42 (0.15) | 1.41 (0.79) | 1.72 (0.59) | ||||
|
Salivaa C. albicans |
4 | 0.65 (0.13) | 0.34(0.05) | 1.25 (0.34) | 1.14 (0.36) |
a,bSignificant at p < 0.05 (ANOVA) for Fluoconazole
N, number of strains; NS, not significant